LUX-Lung trials—not all mutations are created equal

被引:0
|
作者
Lisa Hutchinson
机构
关键词
D O I
10.1038/nrclinonc.2015.9
中图分类号
学科分类号
摘要
引用
收藏
页码:127 / 127
相关论文
共 50 条
  • [21] LUX-Lung: determining the best EGFR inhibitor in NSCLC?
    Rossi, Antonio
    Di Maio, Massimo
    [J]. LANCET ONCOLOGY, 2015, 16 (02): : 118 - 119
  • [22] Afatinib in lung cancer harboring EGFR mutation in the LUX-Lung trials: six plus three is greater than seven?
    Mitsudomi, Tetsuya
    Kobayashi, Yoshihisa
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (04) : 446 - 449
  • [23] Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
    Yang, James Chih-Hsin
    Shih, Jin-Yuan
    Su, Wu-Chou
    Hsia, Te-Chun
    Tsai, Chun-Ming
    Ou, Sai-Hong Ignatius
    Yu, Chung-Jen
    Chang, Gee-Chen
    Ho, Ching-Liang
    Sequist, Lecia V.
    Dudek, Arkadiusz Z.
    Shahidi, Mehdi
    Cong, Xiuyu Julie
    Lorence, Robert M.
    Yang, Pan-Chyr
    Miller, Vincent A.
    [J]. LANCET ONCOLOGY, 2012, 13 (05): : 539 - 548
  • [24] Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
    Yang, James Chih-Hsin
    Wu, Yi-Long
    Schuler, Martin
    Sebastian, Martin
    Popat, Sanjay
    Yamamoto, Nobuyuki
    Zhou, Caicun
    Hu, Cheng-Ping
    O'Byrne, Kenneth
    Feng, Jifeng
    Lu, Shun
    Huang, Yunchao
    Geater, Sarayut L.
    Lee, Kye Young
    Tsai, Chun-Ming
    Gorbunova, Vera
    Hirsh, Vera
    Bennouna, Jaafar
    Orlov, Sergey
    Mok, Tony
    Boyer, Michael
    Su, Wu-Chou
    Lee, Ki Hyeong
    Kato, Terufumi
    Massey, Dan
    Shahidi, Mehdi
    Zazulina, Victoria
    Sequist, Lecia V.
    [J]. LANCET ONCOLOGY, 2015, 16 (02): : 141 - 151
  • [25] Not All RCTs Are Created Equal: Lessons From Early AIDS Trials
    Dawson, Liza
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2015, 15 (04): : 45 - 47
  • [26] LUX-Lung 7: is there enough data for a final conclusion? reply
    Park, Keunchil
    [J]. LANCET ONCOLOGY, 2016, 17 (07): : E268 - E269
  • [27] RAS Mutations Are Not Created Equal
    Hobbs, G. Aaron
    Der, Channing J.
    [J]. CANCER DISCOVERY, 2019, 9 (06) : 696 - 698
  • [28] Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy
    Kobayashi, Yoshihisa
    Mitsudomi, Tetsuya
    [J]. CANCER SCIENCE, 2016, 107 (09) : 1179 - 1186
  • [30] NOT ALL PIXELS ARE CREATED EQUAL
    Grotta, Sally Wiener
    Grotta, Daniel
    [J]. IEEE SPECTRUM, 2012, 49 (05) : 22 - 24